Results

Total Results: 296 records

Showing results for "colorectal outcomes".

21. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening
    June 15, 2016 - Main Outcomes and Measures: Colorectal cancer incidence and mortality, test accuracy in detecting CRC … Potentially important extracolonic findings at screening CT colonography: incidence and outcomes data … Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on … Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal … Outcomes: study did not have relevant outcomes or had incomplete outcomes.

22. Archived: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-june-2016
    June 15, 2016 - diagnostic follow-up, and treatment; they also suggest that equal treatment generally seems to produce equal outcomes … status, comorbid conditions, and prior screening status. 18 Empirical data from randomized trials on outcomes … Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from … Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. … Outcomes are from Cancer Intervention and Surveillance Modeling Network (CISNET) models, which

23. Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/6hyj7-3s6Qxs-brqhxPVxD
    June 06, 2017 - These studies assess the effects of the preventive service on health outcomes. … Low The available evidence is insufficient to assess effects on health outcomes. … lack of information on important health outcomes. … More information may allow estimation of effects on health outcomes. … Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening.Cancer

24. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
    November 01, 2021 - MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality, test accuracy in detecting CRC … Outcomes: study did not have relevant outcomes or had incomplete outcomes. … Potentially important extracolonic findings at screening CT colonography: incidence and outcomes data … Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on … Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal

25. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ocULFVqnfy4STqcU2DuPzU
    May 18, 2021 - MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality, test accuracy in detecting cancers … The questions are depicted by linkages that relate interventions and outcomes. … Outcomes: Study did not have relevant outcomes or had incomplete outcomes. … Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal … Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on

26. Archived: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - All persons older than age 50 who are at average risk for colorectal cancer should be screened for colorectal … approximately 20% of all people with colorectal cancer 7 About 5% to 10% of all cases of colorectal … on these outcomes, and the harms associated with aspirin and NSAID use in healthy adults. … (Executive Director, Outcomes Research and Management, Merck & Company, Inc., West Point, PA); and Barbara … Melbourne Colorectal Cancer Study.

27. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
    March 01, 2007 - quently subcategorized according to measures of dose ef- fect, duration of exposure, and secondary outcomes … Cardiovascular Outcomes with Aspirin Use* Outcome Primary Cardiovascular Prevention Outcomes (95% CI … ) (Reference) Secondary Cardiovascular Prevention Outcomes (95% CI) (Reference) All-cause mortality … (325 mg every other day and 100 mg every other day, respectively), and both used self-reporting of outcomes … The cardiovascular outcomes associated with the use of aspirin depend on the underlying cardiovascular

28. Screening for Colorectal Cancer: A Targeted, Updated Systematic Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/UCajZVxQEKLCgs59HV7ddE
    November 01, 2008 - outcomes in average-risk popula- tions and were at least of fair quality according to design-specific … on health outcomes. … A multilevel model framework for meta-analysis of clinical trials with binary outcomes. … Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal … ) or health outcomes.

29. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
    March 15, 2007 - Cardiovascular Outcomes with Aspirin Use References Appendix Table 1. … (325 mg every other day and 100 mg every other day, respectively), and both used self-reporting of outcomes … The cardiovascular outcomes associated with the use of aspirin depend on the underlying cardiovascular … Cardiovascular Outcomes with Aspirin Use Outcome Primary Cardiovascular Prevention Outcomes … (95% CI) (Reference) Secondary Cardiovascular Prevention Outcomes (95% CI) (Reference) All-cause

30. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - Cardiovascular Outcomes with Aspirin Use References Appendix Table 1. … subsequently subcategorized according to measures of dose effect, duration of exposure, and secondary outcomes … (325 mg every other day and 100 mg every other day, respectively), and both used self-reporting of outcomes … The cardiovascular outcomes associated with the use of aspirin depend on the underlying cardiovascular … Prevention Outcomes (95% CI) (Reference) All-cause mortality No difference OR, 0.93 (0.84

31. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DYFdTVu-UY3h7CWGdA7Zkh
    July 20, 2021 - MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality, test accuracy in detecting cancers … Outcomes: Study did not have relevant outcomes or had incomplete outcomes. … Potentially important extracolonic findings at screening CT colonography: incidence and outcomes data … Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal … Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on

32. Archived: Final Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary4/colorectal-cancer-screening-2008
    October 15, 2008 - on health outcomes. … A multilevel model framework for meta-analysis of clinical trials with binary outcomes. … Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal … ) or health outcomes. … All important outcomes considered.

33. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/vw-LTWCTZ_N5pAaydcNQTx
    June 21, 2016 - MAIN OUTCOMES AND MEASURES Life-years gained compared with no screening (benefit), lifetime number of … As a result, predicted outcomes from the models reflect the potential lifetime benefits, burden, and … Screening Outcomes Benefit of screening was measured by the number of life-years gained (LYG) from the … cancer Non–colorectal cancer death Clinical (diagnosed) colorectal cancer Colorectal cancer death … Outcomes Among a Cohort of 40-Year-Olds Undergoing CRC Screening Outcomes for all screening strategies

34. U.S. Preventive Services Task Force Issues Draft Recommendation on Screening for Colorectal Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/colorectal-cancer-screening-draft-rs-bulletin-updated.pdf
    November 23, 2020 - Preventive Services Task Force Issues Draft Recommendation on Screening for Colorectal Cancer Colorectal … Despite strong evidence that screening for colorectal cancer is effective, about a quarter of people … Black adults get colorectal cancer more often than other populations and are more likely to die from … “Screening earlier will help prevent more people from dying from colorectal cancer.” … He is director of the Virginia Ambulatory Care Outcomes Research Network and director of community-engaged

35. Archived: Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/colorectal-cancer-screening-june-2016
    June 15, 2016 - Main Outcomes and Measures: Life-years gained compared with no screening (benefit), lifetime number … As a result, predicted outcomes from the models reflect the potential lifetime benefits, burden, and … Screening Outcomes Benefit of screening was measured by the number of life-years gained (LYG) from … Outcomes Among a Cohort of 40-Year-Olds Undergoing CRC Screening Outcomes for all screening strategies … In general, while the models differed slightly in terms of absolute outcomes (eg, number of LYG from

36. Archived: Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
    June 15, 2016 - Main Outcomes and Measures: Colorectal cancer incidence and mortality, test accuracy in detecting CRC … Potentially important extracolonic findings at screening CT colonography: incidence and outcomes data … Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on … Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal … Outcomes: study did not have relevant outcomes or had incomplete outcomes.

37. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
    March 15, 2007 - subsequently subcategorized studies based on measures of dose effect, duration of exposure, and secondary outcomes … mortality rates were similar between rofecoxib (0.5%) and naproxen (0.4%) in the Vioxx Gastrointestinal Outcomes … On the other hand, COX-2 inhibitors are associated with an increased risk for adverse cardiovascular outcomes … that, as a group, COX-2 inhibitors are associated with an increased risk for adverse cardiovascular outcomes … Dur- ation Population Control Group Exposure (Ascertain- ment) Outcomes

38. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - subsequently subcategorized studies based on measures of dose effect, duration of exposure, and secondary outcomes … mortality rates were similar between rofecoxib (0.5%) and naproxen (0.4%) in the Vioxx Gastrointestinal Outcomes … On the other hand, COX-2 inhibitors are associated with an increased risk for adverse cardiovascular outcomes … that, as a group, COX-2 inhibitors are associated with an increased risk for adverse cardiovascular outcomes … Dur- ation Population Control Group Exposure (Ascertain- ment) Outcomes

39. Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication
    January 30, 2020 - in progress Draft Research Plan Aspirin Use to Prevent Cardiovascular Disease and Colorectal … Expand All Proposed Analytic Framework Abbreviations: CRC = colorectal … Does regular aspirin use in patients without known cardiovascular disease (CVD) reduce CVD and colorectal … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes … The decision model is a mathematical simulation that projects the health outcomes that result from aspirin

40. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
    March 01, 2007 - subsequently subcategorized studies based on measures of dose effect, duration of exposure, and secondary outcomes … On the other hand, COX-2 inhibitors are associated with an increased risk for adverse cardiovascular outcomes … , as a group, COX-2 inhib- itors are associated with an increased risk for adverse car- diovascular outcomes … Reference) Location Treatment/ Placebo, n/n Duration Population Control Group Exposure (Ascertainment) Outcomes … tubulovillous histology); high-grade dysplasia; intramucosal carcinoma or invasive cancer; cardiovascular outcomes